Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 22.18% is 33% above its 5-year average of 16.73%, near the high end of its 5-year range (12.91%–22.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.16% above its 12-month average of 20.50%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
22.18%
OPERATING MARGIN AVG TTM
20.50%
OPERATING MARGIN AVG 3Y
17.81%
OPERATING MARGIN AVG 5Y
16.73%
OPERATING MARGIN AVG 10Y
16.18%
OPERATING MARGIN AVG 15Y
13.98%
OPERATING MARGIN AVG 20Y
13.01%
CURRENT VS TTM AVG
+8.16%
CURRENT VS 3Y AVG
+24.48%
CURRENT VS 5Y AVG
+32.58%
CURRENT VS 10Y AVG
+37.04%
CURRENT VS 15Y AVG
+58.63%
CURRENT VS 20Y AVG
+70.42%
SECTOR MEDIAN · HEALTHCARE
15.61%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+42.06%
vs the sector median at left
Boston Scientific Corporation
Market Cap
$69.46B
Operating Margin
22.18%
TTM Avg
20.50%
3Y Avg
17.81%
5Y Avg
16.73%
Market Cap
$78.57B
Operating Margin
24.74%
TTM Avg
26.52%
3Y Avg
32.61%
5Y Avg
38.03%
Market Cap
$60.00B
Operating Margin
10.61%
TTM Avg
11.84%
3Y Avg
11.67%
5Y Avg
10.68%
Market Cap
$81.51B
Operating Margin
3.51%
TTM Avg
4.55%
3Y Avg
4.90%
5Y Avg
5.40%
Market Cap
$53.87B
Operating Margin
0.92%
TTM Avg
0.79%
3Y Avg
0.40%
5Y Avg
-0.13%
Market Cap
$87.16B
Operating Margin
15.67%
TTM Avg
15.38%
3Y Avg
15.15%
5Y Avg
15.20%
Market Cap
$49.56B
Operating Margin
28.09%
TTM Avg
26.16%
3Y Avg
28.11%
5Y Avg
28.79%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $69.46B | 22.18% | 20.50% | 17.81% | 16.73% |
| Cigna Corporation (CI)vs › | $73.82B | 3.46% | 3.56% | 4.04% | 4.30% |
| Cencora, Inc. (COR)vs › | $60.57B | 1.28% | 1.08% | 1.06% | 1.09% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.57B | 24.74% | 26.52% | 32.61% | 38.03% |
| Becton, Dickinson and Company (BDX)vs › | $60.00B | 10.61% | 11.84% | 11.67% | 10.68% |
| Elevance Health Inc. (ELV)vs › | $81.51B | 3.51% | 4.55% | 4.90% | 5.40% |
| Cardinal Health, Inc. (CAH)vs › | $53.87B | 0.92% | 0.79% | 0.40% | -0.13% |
| HCA Healthcare, Inc. (HCA)vs › | $87.16B | 15.67% | 15.38% | 15.15% | 15.20% |
| Edwards Lifesciences Corporation (EW)vs › | $49.56B | 28.09% | 26.16% | 28.11% | 28.79% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.10B | 31.63% | 30.27% | 29.30% | 28.64% |
Gross Margin
71.2%
Operating Margin
22.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 22.18% |
| 2026-03-31 | 20.60% |
| 2025-12-31 | 22.81% |
| 2025-09-30 | 20.73% |
| 2025-06-30 | 16.18% |
| 2025-03-31 | 19.22% |
| 2024-12-31 | 12.91% |
| 2024-09-30 | 16.01% |
| 2024-06-30 | 18.13% |
| 2024-03-31 | 16.70% |
| 2023-12-31 | 14.98% |
| 2023-09-30 | 15.82% |
| 2023-06-30 | 15.31% |
| 2023-03-31 | 15.20% |
| 2022-12-31 | 13.85% |
| 2022-09-30 | 14.51% |
| 2022-06-30 | 14.70% |
| 2022-03-31 | 15.10% |
| 2021-12-31 | 14.61% |
| 2021-09-30 | 15.08% |
| 2021-06-30 | 16.61% |
| 2021-03-31 | 13.08% |
| 2020-12-31 | 6.43% |
| 2020-09-30 | 9.85% |
| 2020-06-30 | -3.05% |
| 2020-03-31 | 8.77% |
| 2019-12-31 | 14.08% |
| 2019-09-30 | 14.67% |
| 2019-06-30 | 16.38% |
| 2019-03-31 | 17.21% |
| 2018-12-31 | 16.56% |
| 2018-09-30 | 17.18% |
| 2018-06-30 | 17.95% |
| 2018-03-31 | 19.21% |
| 2017-12-31 | 18.44% |
| 2017-09-30 | 16.92% |
| 2017-06-30 | 17.50% |
| 2017-03-31 | 14.26% |
| 2016-12-31 | 14.51% |
| 2016-09-30 | 15.96% |
| 2016-06-30 | -15.71% |
| 2016-03-31 | 14.92% |
| 2015-12-31 | -13.70% |
| 2015-09-30 | -15.84% |
| 2015-06-30 | 11.88% |
| 2015-03-31 | 1.36% |
| 2014-12-31 | 5.67% |
| 2014-09-30 | 3.47% |
| 2014-06-30 | -3.68% |
| 2014-03-31 | 11.10% |
| 2013-12-31 | 6.91% |
| 2013-09-30 | 5.94% |
| 2013-06-30 | 12.16% |
| 2013-03-31 | -18.74% |
| 2012-12-31 | 6.32% |
| 2012-09-30 | -37.75% |
| 2012-06-30 | -186.65% |
| 2012-03-31 | 10.50% |
| 2011-12-31 | 9.20% |
| 2011-09-30 | 9.28% |
| 2011-06-30 | 12.00% |
| 2011-03-31 | 15.38% |
| 2010-12-31 | 17.38% |
| 2010-09-30 | 13.10% |
| 2010-06-30 | 11.98% |
| 2010-03-31 | -75.82% |
| 2009-12-31 | -59.21% |
| 2009-09-30 | 17.04% |
| 2009-06-30 | 13.26% |
| 2009-03-31 | 0.55% |
| 2008-12-31 | -120.73% |
| 2008-09-30 | 1.42% |
| 2008-06-30 | 14.97% |
| 2008-03-31 | 28.35% |
| 2007-12-31 | -19.97% |
| 2007-09-30 | -7.18% |
| 2007-06-30 | 13.52% |
| 2007-03-31 | 13.52% |
| 2006-12-31 | 13.75% |
| 2006-09-30 | 9.62% |
| 2006-06-30 | -186.02% |
| 2006-03-31 | 30.68% |
| 2005-12-31 | 30.19% |
| 2005-09-30 | -22.24% |
| 2005-06-30 | 20.16% |
| 2005-03-31 | 31.76% |
| 2004-12-31 | 31.50% |
| 2004-09-30 | 24.16% |
| 2004-06-30 | 30.68% |
| 2004-03-31 | 24.40% |
| 2003-12-31 | 20.87% |
| 2003-09-30 | 19.75% |
| 2003-06-30 | 20.26% |
| 2003-03-31 | 19.21% |
| 2002-12-31 | 19.29% |
| 2002-09-30 | 34.07% |
